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ABSTRACT 
 
Background: Pulmonary tuberculosis is a communicable disease caused by mycobacterium tuberculosis. Serum 
albumin is a more accurate indicator of crucial fat-free mass and survival in patients treated for tuberculosis. 
Objective: To study the role of serum albumin as biochemical marker for monitoring the nutritional status in newly 
diagnosed tuberculosis patients during treatment. 
Methodology: This was a longitudinal study carried out in Mahatma Gandhi Medical College and Research 
Institute, Puducherry. All the patients who satisfied inclusion criteria received tuberculosis chemotherapy. All the 
indices like Weight, Body Mass Index (BMI), Serum Albumin and sputum for Acid Fast Bacilli (AFB) were 
estimated before start of treatment and followed up once in two months until completion of treatment.  
Results: Out of the 77 patients started the study, 50 patients completed the study. The pre-treatment mean weight, 
Body Mass Index and Serum albumin were 46.78kg, 17.22kg/m2 and 25.68g/L respectively. The corresponding 
values at the end of six months of treatment were 52.86 kg, 19.09kg/m2 and 40.14g/L. These three variables showed 
significant improvement with treatment. Serum albumin showed statistically significant improvement with treatment 
when compared to weight and Body Mass Index. 
Conclusion: Both the Serum albumin and Body Mass Index pre-treatment values reveal that patients are 
malnourished at presentation. Serum albumin is more sensitive and reliable marker than weight and Body mass 
index for patients with tuberculosis that have an average of monthly visits to hospitals. 
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Introduction 
 
 
Pulmonary tuberculosis is a communicable disease of 
global importance caused by mycobacterium 
tuberculosis. Tuberculosis (TB) is on the increase 
throughout the world and is one of the leading causes 
of death among adults in developing countries like 
India. In 1993, the World Health Organization declared 
tuberculosis to be a “global health emergency [1].  
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Despite  the  availability  of  effective therapy for TB,  
it continues  to  infect  an  estimated  one-third of the 
world's population, to cause  disease in 8.8 million 
people per year, and to kill 1.6 million of those 
afflicted with disease [2]. India  has  the  highest  
number of TB cases in  the world and it is second 
leading cause of death among all diseases [3]. 
In most of the underdeveloped and developing 
countries of the world both tuberculosis and 
malnutrition are still problems of considerable 
magnitude [4]. Malnutrition may predispose people to 
development of disease and tuberculosis can contribute 
to malnutrition [5]. The risk of tuberculosis is higher 
among men who were at least 10% underweight at 
baseline by nearly four-fold than in men who were at 
least 10% overweight [6]. In tuberculosis, weight loss 
is one of the most obvious manifestations of nutritional 
wasting. The bulk of weight loss in patients with 
 Asian Pac. J. Health Sci., 2014; 1(4): 486-491                                        e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Nalabothu et al ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2014; 1(4): 486-491 
www.apjhs.com      487 
 
tuberculosis is fat mass, though the fat free component, 
which is also lost in significant amounts, certainly has 
more of an effect on the physical functioning of 
patient. Protein deficiency has been described in the 
context of tuberculosis, Protein calorie malnutrition has 
been identified as an essential risk factor for the 
predisposition to intracellular infection and leading to 
death [7].Serum albumin has a half-life of 21days, it is 
a good index of body nutrition, more so for patients 
with pulmonary tuberculosis that have an average of 
monthly visits to the clinics. 
Previous studies by Schwenk et al and Adebisi SA et al 
have shown that protein is one of the major 
components lost during an episode of tuberculosis; it is 
not significantly regained during the course of 
treatment, making overall weight gain an inadequate 
clinical marker for following the reversal of TB 
wasting.Serum albumin may be a more accurate 
indicator than weight of improving nutritional status 
[especially with regard to crucial fat-free mass] in 
patient treated for tuberculosis [8, 9]. 
This study was therefore carried out to determine the 
degree of malnutrition among patients with pulmonary 
tuberculosis using their Body Mass Index and serum 
albumin levels and to evaluate role of serum albumin 
as Biochemical marker for monitoring nutritional status 
of newly diagnosed smear positive pulmonary 
tuberculosis patients during treatment. 
 
Methodology 
 
The study was carried out in the department of 
Pulmonary Medicine, Mahatma Gandhi Medical 
College and Research Institute, pillayarkuppum, 
Puducherry, India after the clearance of the 
Institutional Human Ethical committee (IHEC). This is 
a prospective, longitudianl study that involves humans.  
 
Inclusion Criteria 
1. Newly diagnosed pulmonary tuberculosis who is 
atleast one sputum specimen positive for Acid-
Fast bacilli (AFB) by microscopy. 
2. Age above 18years. 
Exclusion Criteria 
1. Patients with Abnormal liver function as 
measured by increased serum levels of Aspartate 
amino transferase (AST), Alanine amino 
transferase (ALT) and Bilirubin levels. 
2. Chronic renal failure as determined by elevated 
levels of serum urea and creatinine. 
3. Patients with diabetes mellitus as measured by 
fasting blood glucose levels. 
4. Patients on long term Acetaminophen and Statin 
therapy. 
5. Patients with Hypoprotenaemia. 
 
All the Patients who satisfied the inclusion criteria 
attending the Pulmonary Medicine Out Patient 
Department from December 2012 to January 2014 
received Directly Observed Treatment Shortcourse 
(DOTS) chemotherapy for 6 months Category I under 
Revised National Tuberculosis Control Programme 
(RNTCP) This consists of Isoniazid, Rifampicin, 
Ethambutol and Pyrazinamide. Pyrazinamide and 
Ethambutol were used only for the first two months of 
the therapy. 
In all the patients weight was measured using a 
weighing machine. Height was measured using a 
standard scale without wearing foot wear. Body Mass 
Index (BMI) was calculated using Quetelet’s Index. 
Serum albumin levels were measured by Bromocresol 
green method [10]. 
Each patient was followed up for a period of six 
months. All the indices like Weight, BMI, Serum 
Albumin and sputum AFB were estimated on the first 
day of visit before start of treatment and followed up 
once in two months until completion of treatment.  
SPSS version 19.0 (IBM SPSS, US) was used to 
analyze the data. The quantitative variables have been 
described as mean ± SD or Frequency analysis with 
numbers and percentage. Since data does not follow 
normal distribution non-parametric test Kruskal Wallis 
test and wilcoxon signed rank test are the statistical 
tests used for testing the hypothesis. Value of p< 0.05 
was considered significant. 
Results 
 
Out of the 77 patients started the study, 27 of them 
were lost to follow up, while the remaining 50 patients 
followed up in department of pulmonary medicine, 
Mahatma Gandhi Medical College & Research 
Institute, Puducherry and  completed the study. The 50 
patients were made up of 32(64%) males and 18(36%) 
females. These patients by using pre-treatment data 
served as their own controls against which subsequent 
data were compared. 
 
Table I shows frequency of gender among patients. It is 
shows that majority of the patients are males 32(64%) 
and only 18(36%) of the patients are females.  
Table II shows the mean values of weight, Body Mass 
Index and serum albumin of the patients.Both the Body 
Mass Index (BMI) and Serum Albumin pre-treatment 
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values show clearly that the patients were 
malnourished at presentation.  
Table III shows the results of analysis with wilcoxon 
signed rank test, using the pre-treatment values and the 
post treatment values of weight, Body Mass Index and 
serum albumin.The critical value ratio calculated (z-
test) was -6.185, -6.161 and -6.179, while their 
corresponding p-values were 0.000, 0.000 and 0.000 
respectively.This shows that with treatment there was 
significant improvement in all theoutcome variables.  
Table IV shows further analysis of mean values of the 
patient’s weight, Body Mass Index and serum albumin 
with Kruskal-wallis test gave a chi square 
value/kruskal-Wallis H of 10.074, 17.895 and 141.053, 
while their corresponding p-values were 0.018, 0.000 
and 0.000 respectively.This that the weight, Body Mass 
Index and serum albumin had changed significantly; 
the serum albumin with chi square value of 141.053 is 
the most sensitive. 
 
 
 
Table I: Frequency of Gender 
 
Gender Frequency Percent (%) 
Male 32 64.0 
Female 18 36.0 
Total 50 100.0 
 
Table II: Mean and Standard deviation of Weight, Body Mass Index (BMI), and Serum Albumin before 
treatment, end of 2nd month, end of 4th month and at the end of treatment 
Variable Before 
Treatment 
After 2 months of 
ATT 
After 4 months of 
ATT 
End of treatment 
 Mean SD Mean SD Mean SD Mean SD 
Weight(kg) 46.7800 10.
17 
49.7400 9.83 51.3200 9.81 52.8600 9.92 
BMI(kg/m2) 17.2280 2.2
3 
18.0860 2.14 18.6080 2.09 19.0980 2.09 
Serum 
Albumin(g/L) 
25.6800 3.7
2 
33.2200 3.54 36.6400 3.13 40.1400 3.18 
 
Table III: Wilcoxon-signed rank test analysis of pre-treatment and end of treatment values of weight, Body 
Mass Index (BMI) and Serum Albumin. 
  N Mean 
Rank 
Sum of 
Ranks 
z- 
test 
P-
valu
e 
Weight(kg) - Weight(kg) Negative 
Ranks 
0
a
 
.00 .00 -
6.185
b 
 
 
 
0.000 
Positive 
Ranks 
5
0
b
 
25.50 1275.00 
Ties 0
c
 
  
Total 5
0 
  
BMI(kg/m2) - BMI(kg/m2) Negative 0 .00 .00 - 0.000 
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Ranks d 6.161
b
 Positive 
Ranks 
5
0
e
 
25.50 1275.00 
Ties 0
f
 
  
Total 5
0 
  
Serum Albumin(g/L) – Serum 
Albumin(g/L) 
Negative 
Ranks 
0
g
 
.00 .00 -
6.179
b
 
0.000 
Positive 
Ranks 
5
0
h
 
25.50 1275.00 
Ties 0
i
 
  
Total 5
0 
  
a. Weight(kg) <Weight(kg)  
b. Weight(kg) >Weight(kg) 
c. Weight(kg) = Weight(kg) 
d. BMI(kg/m2) <BMI(kg/m2) 
e. BMI(kg/m2) >BMI(kg/m2) 
f. BMI(kg/m2) = BMI(kg/m2) 
g. Serum Albumin(g/L) <Serum Albumin(g/L) 
h. Serum Albumin(g/L) >Serum Albumin(g/L) 
i. Serum Albumin(g/L) = Serum Albumin(g/L) 
 
Table IV: Kruskal-Wallis test for analysis of weight (kg), Body Mass Index (BMI) and Serum Albumin (g/L) 
 Group N Mean 
Rank 
Chi-square 
value/Krush
al-Wallis H 
P-value 
Weight (kg) Pre Treatment BMI(kg/m2) 50 80.93 10.074 0.018 
After 2 months of ATT BMI(kg/m2) 50 97.89 
After 4 months of ATT BMI(kg/m2) 50 107.21 
End of treatment BMI(kg/m2) 50 115.97 
Total 200  
BMI (kg/m2) Pre Treatment BMI(kg/m2) 50 74.93 17.895 0.000 
After 2 months of ATT BMI(kg/m2) 50 96.10 
After 4 months of ATT BMI(kg/m2) 50 109.31 
End of treatment BMI(kg/m2)                        
50 
121.66   
Total 200    
Serum 
Albumin(g/L) 
Pre Treatment BMI(kg/m2) 50 29.36 141.053 0.000 
After 2 months of ATT BMI(kg/m2) 50 87.73 
After 4 months of ATT BMI(kg/m2) 50 124.03 
End of treatment BMI(kg/m2) 50 160.88 
Total 200  
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Discussion 
The study was carried out in the department of 
Pulmonary Medicine, Mahatma Gandhi Medical 
College & Research Institute (MGMC&RI)  
pillayarkuppum, Puducherry  after the clearance of the 
Institutional Human Ethical committee (IAEC).This 
study was carried out over a period of one and half year 
from December 2012 to July 2014. 
Through this study, an attempt was made to study the 
role of serum albumin as biochemical marker for 
monitoring the nutritional status in newly diagnosed 
smear positive pulmonary tuberculosis patients during 
treatment and to find out association between sputum 
conversion and serum albumin levels at the end of 
intensive phase of treatment. 
Out of the 77 patients started the study, 27 of them 
were lost to follow up, while the remaining 50 patients 
followed up in department of pulmonary medicine, 
Mahatma Gandhi Medical College & Research 
Institute (MGMC&RI) and  completed the study. The 
50 patients were made up of 32(64%) males and 
18(36%) females. Out of 50 patients 33(66%) patients 
had low Body Mass Index (BMI) and 17(34%) patients 
had normal Body Mass Index (BMI) with a mean Body 
Mass Index (BMI) of 17.22kg/m2 at start of treatment. 
This shows a clear association between undernutrition 
and incidence of tuberculosis. Similar reports were 
given by Edwards LB et al and Tverdal A et al [6, 11].  
In our present study, pre-treatment Serum albumin 
(25.68g/L) was significantly lower in patients with 
pulmonary tuberculosis. The lower levels of serum 
albumin in the present study might have been due to 
poor appetite, malnutrition and mal-absorption 
commonly observed in tuberculosis. Similar reports 
were given by Yamagishi et al and Cegielski JP et al 
[12, 13]. 
In our study, Weight, Body Mass Index 
(BMI), Serum albumin values of the patients showed a 
steady improvement as the treatment progressed. The 
pre-treatment mean weight, Body Mass Index (BMI) 
and Serum albumin were 46.78kg, 17.22kg/m2 and 
25.68g/L respectively. The corresponding values at the 
end of six months of treatment were 
52.86kg,19.09kg/m2 and 40.14g/L.The consistent 
upward trends of these parameters during treatment 
show that they may be reliable markers of nutritional 
status for monitoring tuberculosis.   
Subjecting the patients pre-treatment 
value and the post treatment value of weight, Body 
Mass Index (BMI) and serum albumin using wilcoxon 
signed rank test, The critical value ratio calculated (z-
test) was -6.185, -6.161 and -6.179,while their 
corresponding p-values were 0.000, 0.000 and 0.000 
respectively.This shows that with treatment there was 
significant improvement in all the outcome 
variables.Similar observation was mentioned by 
Adebisi S.A et al [8]. 
Subjecting the patients pre-treatment value and the post 
treatment value of weight, Body Mass Index (BMI) and 
serum albumin using wilcoxon signed rank test, The 
critical value ratio calculated (z-test) was -6.185, -
6.161 and -6.179 ,while their corresponding p-values 
were 0.000, 0.000 and 0.000 respectively. This shows 
that with treatment there was significant improvement 
in all theoutcome variables. Similar observation was 
mentioned byAdebisi S.A et al [8]. 
Conclusion 
This study suggests that weight, Body Mass Index 
(BMI) and serum albumin are very reliable markers of 
nutritional status in patients with newly diagnosed 
smear positive pulmonary tuberculosis. Of these three 
parameters, serum albumin is the most sensitive. Since 
serum albumin is free from some of the short comings 
of weight and body Mass Index (BMI) like drug 
induced vomiting and diarrhoea. As serum albumin is a 
relatively easily available biochemical marker can be 
used in addition to weight and Body Mass Index (BMI) 
in monitoring the nutritional status of patients with 
pulmonary tuberculosis.      
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